speb/financial-data huggingface dataset:
TRANSPEK.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 2552239000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2552239000.00
TRANSPEK.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 6994427000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6994427000.00
TRANSPEK.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1334576000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1334576000.00
TRANSPEK.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 19644000.00
TRANSPEK.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
TRANSPEK.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TRANSPEK.NS balance_sheet (annual, 2025-03-31) — Work In Process: 274552000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 274552000.00
TRANSPEK.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1793339000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1793339000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 658274000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1542332000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 5584480.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 27.90
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 766789000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 123217000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 123217000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 5584480.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 27.90
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — EBIT: 233882000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — EBITDA: 357099000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 775543000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 24575000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 24575000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Income: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -24575000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -24575000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 357099000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 155807000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Operating Income: 117269000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1542332000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 116613000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 351900000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 209307000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 766789000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 123217000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 53500000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1425063000.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 733870000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1602724000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 614048000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 929009000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 3521732000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 5587356.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 22.62
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 454461000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 55856000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 188116000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1045315000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 55856000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 7679355000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 127471000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 725370000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 2904125000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 155553000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 38030000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 193583000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 988605000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 10004000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 123369000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 123369000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 5587356.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 22.62
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — EBIT: 193772000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — EBITDA: 317141000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 172000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3544609000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 877354000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 24111000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 24111000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 718508000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 7931962000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 3521732000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 298908000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 214577000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 513485000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 32145000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 64491000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Income: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -24111000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -24111000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 3544609000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 7679183000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 784988000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 317141000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 126386000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Operating Income: 143484000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1602724000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5585569.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 211293000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 47233000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 7623499000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 172000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 27940000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 50288000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 429125000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 3417138000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 857199000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Payables: 614048000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 169661000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 725370000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 123369000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 5585569.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 7679355000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 7679183000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 43275000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 9998578000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7893932000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 707068000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 7679355000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 1459240000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2319223000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7094453000.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1330618000.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
TRANSPEK.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1915520000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 767402000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1584779000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 5584758.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 19.42
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 691481000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 123403000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 123403000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 5584758.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 19.42
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — EBIT: 161308000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — EBITDA: 284711000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 893298000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 16672000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 16672000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Income: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -16672000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -16672000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 284711000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 108456000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Operating Income: 125896000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1584779000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 35412000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 452241000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 144636000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 691481000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 123403000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 36180000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1458883000.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — +Operating Expense: 2858351000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 698806000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — +Total Revenue: 6211990000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1482154000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1503081000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1503081000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 3208816000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3208816000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 5585993.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 11.78
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 565181000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -382427000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 148867000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 148867000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 55856000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 55856000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 578311000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 578311000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1172022000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1172022000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -111711000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 168126000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 94027000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 13989000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Change In Payable: 51329000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -474145000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -144840000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 13129000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Common Stock: 55856000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 55856000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 7674415000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7674415000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 45996000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 45996000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2906164000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 722524000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Current Assets: 3365364000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 3365364000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1326683000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1326683000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Depreciation: 486405000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 486405000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 486405000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 116417000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 486405000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 116417000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 5585993.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 11.78
TRANSPEK.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 65803000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 58828000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — EBIT: 692519000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — EBIT: 103555000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — EBITDA: 1178924000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — EBITDA: 219972000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — End Cash Position: 578311000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -396516000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 402258000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -58828000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 10930000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 168000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 168000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 3476146000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3476146000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Gross Profit: 3305826000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 759630000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Interest Expense: 80574000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 15215000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 80574000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 15215000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -78834000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 59809000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Inventory: 503215000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 503215000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 7818133000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7818133000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -375040000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 3208816000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 3208816000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 148867000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 148867000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 143718000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 143718000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 292585000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 292585000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 34500000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 34500000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 11115000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Income: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Income: 65803000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 65803000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 65803000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 65803000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 65803000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 611945000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 65803000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Interest Income: -80574000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -15215000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -122268000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 47073000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -62074000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -80574000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -15215000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -1214000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Net PPE: 3476146000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 3476146000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -370195000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 109147000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 7674247000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7674247000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 754954000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 754954000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1178924000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 219972000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Normalized Income: 456454000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 65803000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 784685000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Operating Income: 447475000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Operating Income: 60824000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Operating Revenue: 6211990000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1482154000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 5585569.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 5585569.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 187046000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 187046000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 7618559000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 7618559000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 168000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 168000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 10533000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 32643000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 32643000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 245044000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 42731000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1639346000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 406081000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Other Properties: 3430150000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 3430150000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 593711000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 593711000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Pretax Income: 611945000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 88340000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -248000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -382427000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 2906164000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 722524000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 486405000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 116417000.00
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 12232000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Share Issued: 5585569.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 5585569.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 7674415000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7674415000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 7674247000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7674247000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Tax Provision: 155491000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 22537000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
TRANSPEK.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -142327000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Total Assets: 10083137000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 10083137000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 7818133000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7818133000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Total Debt: 292585000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 292585000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 7674415000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7674415000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Total Expenses: 5764515000.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1421330000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2408722000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2408722000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 6717773000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 6717773000.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1082039000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1082039000.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
TRANSPEK.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TRANSPEK.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TRANSPEK.NS balance_sheet (annual, 2026-03-31) — Working Capital: 2038681000.00
TRANSPEK.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 2038681000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1994590000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 875230000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -94790000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Amortization: 2280000.00
TRANSRAILL.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 2280000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 124099884.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Basic EPS: 5.21
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1422230000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 40060000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 534980000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Assets: 228810000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 17950000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 124099884.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Diluted EPS: 5.21
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Financial Assets: 0.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 621500000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 829850000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 6492140000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 33640000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Interest Income: 48870000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 48870000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 0.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 754240000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 2967690000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 0.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 44030000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 300280000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 14040000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 2380000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 333150000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Other Payable: 133880000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Other Special Charges: -200000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 285060000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1256170000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1684580000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 197970000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 197970000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 564300000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 4854090000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1136390000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1966240000.00
TRANSRAILL.NS cash_flow (annual, 2022-03-31) — Stock Based Compensation: 0.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 0.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 615220000.00
TRANSRAILL.NS balance_sheet (annual, 2022-03-31) — Work In Process: 145630000.00
TRANSRAILL.NS income_statement (annual, 2022-03-31) — Write Off: 39220000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — +Operating Expense: 5622920000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — +Total Revenue: 30861370000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 13075340000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 6448950000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -2347510000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 886510000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -95000000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Amortization: 550000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 550000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 2430000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 124099884.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Basic EPS: 8.67
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 575040000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1586870000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -539500000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 163510000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 227980000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1247140000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1261680000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 38240000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 1208900000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -325110000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 426260000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 134600000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Change In Payable: 2369480000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -3861120000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1255890000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 672100000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Common Stock: 227980000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 7713970000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 8670000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 90440000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 22232930000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Assets: 29463440000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 80350000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Debt: 4845820000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 4926170000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Assets: 163970000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 24180000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 24844560000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 453920000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Depreciation: 457710000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 458260000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 458260000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 457710000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 124099884.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Diluted EPS: 8.67
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 1075680000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — EBIT: 2555570000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — EBITDA: 3013830000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — End Cash Position: 1247140000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 0.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 290610000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 694530000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 887290000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -810000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 20240000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 686030000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1950000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 6543950000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 6225290000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Gross Profit: 8628440000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 45980000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Interest Expense: 1072630000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1072630000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Interest Income: 81630000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 81630000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1014000000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 62510000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Inventory: 3109960000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 13763190000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1045300000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 0.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 0.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 8670000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 1004500000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 754240000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 83160000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1203400000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1286560000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 1004500000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1191150000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3638120000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 8670000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Net Debt: 4802080000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -171330000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Income: 1075680000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1075680000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1075680000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1075680000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1075680000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1473200000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1075680000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Interest Income: -1805650000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 1358070000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -186650000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1805650000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -486570000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3877780000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -518170000.00
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 1544720000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 7712020000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Non Current Accrued Expenses: 0.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 43070000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 365940000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 2992690000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Normalized Income: 1060345680.88
TRANSRAILL.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1426790000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Operating Income: 3005520000.00
TRANSRAILL.NS income_statement (annual, 2023-03-31) — Operating Revenue: 30861370000.00
TRANSRAILL.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 134256025.00